pI: 7.8755 |
Length (AA): 1288 |
MW (Da): 143537 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | epimastigote, metacyclic. | Smircich P |
Smircich P | Ribosome profiling reveals translation control as a key mechanism generating differential gene expression in Trypanosoma cruzi. |
Ortholog group members (OG5_128362)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT1G51040 | phosphatidylinositol 4-kinase alpha 2 |
Arabidopsis thaliana | AT1G49340 | phosphatidylinositol 4-kinase alpha |
Brugia malayi | Bm1_45855 | hypothetical protein |
Brugia malayi | Bm1_45860 | phosphatidylinositol 4-kinase, catalytic, alpha polypeptide |
Candida albicans | CaO19.1814 | Phosphatidylinositol-4-kinase. |
Candida albicans | CaO19.9377 | Phosphatidylinositol-4-kinase. |
Caenorhabditis elegans | CELE_Y75B8A.24 | Protein Y75B8A.24 |
Dictyostelium discoideum | DDB_G0277537 | phosphatidylinositol 4-kinase |
Drosophila melanogaster | Dmel_CG10260 | Phosphatidylinositol 4-kinase III alpha |
Echinococcus granulosus | EgrG_000799800 | phosphatidylinositol 4 kinase alpha |
Entamoeba histolytica | EHI_148700 | phosphatidylinositol 4-kinase, putative |
Echinococcus multilocularis | EmuJ_000799800 | phosphatidylinositol 4 kinase alpha |
Homo sapiens | ENSG00000241973 | phosphatidylinositol 4-kinase, catalytic, alpha |
Leishmania braziliensis | LbrM.29.1540 | phosphatidylinositol 4-kinase alpha, putative |
Leishmania donovani | LdBPK_291550.1 | phosphatidylinositol-kinase domain protein, putative |
Leishmania infantum | LinJ.29.1550 | phosphatidylinositol 4-kinase alpha, putative |
Leishmania major | LmjF.29.1450 | phosphatidylinositol 4-kinase alpha, putative |
Leishmania mexicana | LmxM.08_29.1450 | phosphatidylinositol-kinase domain protein, putative |
Loa Loa (eye worm) | LOAG_15974 | hypothetical protein |
Loa Loa (eye worm) | LOAG_12597 | phosphatidylinositol 4-kinase type 3 alpha isoform 1 |
Loa Loa (eye worm) | LOAG_12125 | hypothetical protein |
Mus musculus | ENSMUSG00000041720 | phosphatidylinositol 4-kinase, catalytic, alpha polypeptide |
Neospora caninum | NCLIV_044900 | hypothetical protein |
Oryza sativa | 4333883 | Os03g0711200 |
Saccharomyces cerevisiae | YLR305C | 1-phosphatidylinositol 4-kinase STT4 |
Schistosoma japonicum | Sjp_0123460 | Phosphatidylinositol 4-kinase alpha, putative |
Schistosoma japonicum | Sjp_0082010 | ko:K00888 phosphatidylinositol 4-kinase [EC2.7.1.67], putative |
Schistosoma japonicum | Sjp_0110720 | expressed protein |
Schistosoma japonicum | Sjp_0131040 | Phosphatidylinositol 4-kinase alpha, putative |
Schistosoma japonicum | Sjp_0129560 | Phosphatidylinositol 4-kinase alpha, putative |
Schistosoma mansoni | Smp_053190 | hypothetical protein |
Schistosoma mansoni | Smp_150660 | phosphatidylinositol 4-kinase |
Schmidtea mediterranea | mk4.002463.00 | |
Trypanosoma brucei gambiense | Tbg972.3.4410 | phosphatidylinositol 4-kinase alpha, putative |
Trypanosoma brucei | Tb927.3.4020 | phosphatidylinositol 4-kinase alpha, putative |
Trypanosoma congolense | TcIL3000_3_2660 | phosphatidylinositol 4-kinase alpha, putative |
Trypanosoma congolense | TcIL3000_0_37620 | phosphatidylinositol 4-kinase alpha, putative |
Trypanosoma cruzi | TcCLB.507531.19 | phosphatidylinositol 4-kinase alpha, putative |
Trypanosoma cruzi | TcCLB.510003.30 | phosphatidylinositol 4-kinase alpha, putative |
Trypanosoma cruzi | TcCLB.507533.10 | phosphatidylinositol 4-kinase alpha, putative |
Toxoplasma gondii | TGME49_228690 | phosphatidylinositol 3- and 4-kinase |
Trichomonas vaginalis | TVAG_161620 | phosphatidylinositol 4-kinase, putative |
Trichomonas vaginalis | TVAG_236630 | phosphatidylinositol kinase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.3.4020 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.3.4020 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.3.4020 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.3.4020 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y75B8A.24 | Caenorhabditis elegans | slow growth | wormbase |
YLR305C | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_228690 | Toxoplasma gondii | Essentiality uncertain | sidik |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | phosphatidylinositol 4-kinase, catalytic, alpha | Compounds | References |